David Potter to Humans
This is a "connection" page, showing publications David Potter has written about Humans.
Connection Strength
0.074
-
Ketamine: repurposing and redefining a multifaceted drug. Drug Discov Today. 2014 Dec; 19(12):1848-54.
Score: 0.018
-
Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des. 2012; 18(37):6101-8.
Score: 0.015
-
The opioidergic system: potential roles and therapeutic indications in the eye. J Ocul Pharmacol Ther. 2008 Apr; 24(2):117-40.
Score: 0.012
-
Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005; 11(2):195-212.
Score: 0.009
-
Functional identification of phosphodiesterase activity in human trabecular meshwork cells. J Ocul Pharmacol Ther. 2000 Aug; 16(4):317-22.
Score: 0.007
-
Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1745-52.
Score: 0.006
-
Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res. 1982-1983; 2(5):281-8.
Score: 0.002
-
Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats. Cells Tissues Organs. 2002; 171(2-3):188-98.
Score: 0.002
-
Adrenergic pharmacology of aqueous humor dynamics. Pharmacol Rev. 1981 Sep; 33(3):133-53.
Score: 0.002
-
Adrenergic drugs and intraocular pressure. Gen Pharmacol. 1981; 12(1):1-13.
Score: 0.002